# Boston Scientific to acquire Vertiflex for $465 million

Boston Scientific has agreed to acquire Vertiflex, developer of the Superion Indirect Decompression System for lumbar spinal stenosis, for $465 million upfront plus contingent payments.

- Type: Acquisition
- Announced: 2019-05-09
- Where: United States
- Value: $465.0M
- Status: announced
- Products: Superion Indirect Decompression System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Vertiflex](https://endata.com/companies/39424.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-vertiflex-inc-300846917.html), 2019-05-09: "The acquisition of Vertiflex and the Superion System will further our category leadership strategy by expanding the breadth of our pain management product offerings."
- [biospace.com](https://www.biospace.com/latham-and-watkins-advises-boston-scientific-in-its-acquisition-of-vertiflex), 2019-05-09: "The transaction consists of $465 million in upfront cash and additional payments contingent on commercial milestones for the next three years."
- [news.bostonscientific.com](https://news.bostonscientific.com/2019-06-11-Boston-Scientific-Closes-Acquisition-Of-Vertiflex-Inc), 2019-06-11: "The addition of the Vertiflex procedure to our pain management portfolio advances our pain category leadership strategy, while also providing physicians with additional non-opioid pain management solutions that can help improve the lives of the growing number of patients suffering from chronic pain."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.